Companies: 10,795·Total market cap: $144.5T
Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd.

SNPHYOTCHealthcare● Active
$12.15
+$0.40(+3.38%)
Market Cap$3.9B
P/E Ratio—
52W High$12.68
52W Low$9.22
Overview
股票排行：Drug Manufacturers - General·Healthcare·查看全部市值排行 →

Santen Pharmaceutical Co., Ltd.（SNPHY）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · SNPHY · 截至 Jun 9, 2026

关键指标

EPS (TTM)$116.58snphy eps ttm · snphy earnings per shareEarnings history
PE Ratio (TTM)0.1×snphy pe ratio ttm · snphy price to earningsPE Ratio deep dive
Revenue (TTM)$295.6Bsnphy revenue ttm · snphy annual revenueFull revenue history
Dividend Yield2.00%does snphy pay dividends · snphy dividend yieldDividend history
Shares Outstanding327.6Msnphy shares outstanding · snphy floatShares outstanding history
Next EarningsTBAsnphy earnings date · snphy next earningsEarnings history

探索 Santen Pharmaceutical Co., Ltd. 数据

snphy stock data · financials
市值$3.9Bsnphy market cap · snphy valuation
分析师预测—
股息2.00%does santen pharmaceutical co., ltd. pay dividends · snphy dividend yield
营收$309.2B+3.07%santen pharmaceutical co., ltd. annual revenue · snphy revenue
盈利EPS $121.43+16.78%snphy earnings · snphy eps
市盈率0.1×snphy pe ratio · snphy price to earnings

财务快照

完整财报
FY 2026Revenue$309.21B▲ +3.07% YoY
202420252026
santen pharmaceutical co., ltd. revenue · snphy revenue 2026
FY 2026Net Income$39.62B▲ +9.29% YoY
202420252026
santen pharmaceutical co., ltd. net income · snphy profit 2026
FY 2026EPS$121.43▲ +16.78% YoY
202420252026
snphy eps · santen pharmaceutical co., ltd. earnings per share 2026
TTM:Revenue: $295.63BNet Income: $37.93BEPS: $116.58View income statement →

股票表现

完整历史
1D+3.38%
1W+2.97%
1M+13.66%
3M+19.94%
YTD+17.96%
1Y+6.95%
5Y-11.89%

关于 Santen Pharmaceutical Co., Ltd.

CEOTakeshi Ito
IPO DateAug 31, 2011
Employees3,744
CountryJP
Websitesanten.com

Santen Pharmaceutical Co., Ltd. is a global enterprise dedicated to the research, development, manufacturing, and distribution of pharmaceuticals and medical devices, with operations spanning Japan an…

Drug Manufacturers - GeneralHealthcareOTCADRJP

what is santen pharmaceutical co., ltd. · snphy stock overview · santen pharmaceutical co., ltd. company profile · who is santen pharmaceutical co., ltd. ceo · snphy OTC · santen pharmaceutical co., ltd. headquarters · santen pharmaceutical co., ltd. business segments

关于股票概览与关键数据

Santen Pharmaceutical Co., Ltd.（SNPHY）是 Drug Manufacturers - General 行业的 Healthcare 类公司，于 Aug 31, 2011 在 OTC 上市。截至最近交易日，SNPHY 股价为 $12.15，市值约为 $3.9B。过去12个月累计回报 +6.95%，年初至今回报 +17.96%。

2026 财年 Santen Pharmaceutical Co., Ltd. 营收 $309.2B。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Santen Pharmaceutical Co., Ltd.（SNPHY）股价为 $12.15，在 OTC 上市，52周区间为 $9.22 – $12.68。

SNPHY 最新股价SNPHY quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议